Commentary: Should we always deliberately be non-representative?

[1]  Robert Luben,et al.  Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study , 2001, The Lancet.

[2]  G. Smith.  Epidemiology, epigenetics and the 'Gloomy Prospect': embracing randomness in population health research and practice. , 2011, International journal of epidemiology.

[3]  S. Lewis,et al.  Alcohol Intake and Blood Pressure: A Systematic Review Implementing a Mendelian Randomization Approach , 2008, PLoS medicine.

[4]  F. Clavel-Chapelon,et al.  Meat consumption and mortality - results from the European Prospective Investigation into Cancer and Nutrition , 2013, BMC Medicine.

[5]  G. Smith,et al.  The uses of 'Uses of epidemiology'. , 2001, International journal of epidemiology.

[6]  R. Collins,et al.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[7]  C Bain,et al.  Threats to Applicability of Randomised Trials: Exclusions and Selective Participation , 1999, Journal of health services research & policy.

[8]  An Pan,et al.  Red meat consumption and mortality: results from 2 prospective cohort studies. , 2012, Archives of internal medicine.

[9]  Alan D. Lopez,et al.  Alcohol consumption and mortality among middle-aged and elderly U.S. adults. , 1997, The New England journal of medicine.

[10]  Neil Pearce,et al.  Commentary: Representativeness is usually not necessary and often should be avoided. , 2013, International journal of epidemiology.

[11]  D. Lawlor,et al.  Exploring causal associations between alcohol and coronary heart disease risk factors: findings from a Mendelian randomization study in the Copenhagen General Population Study. , 2013, European heart journal.

[12]  J. Gallacher,et al.  Why representativeness should be avoided. , 2013, International journal of epidemiology.

[13]  J. Bell,et al.  The value of twins in epigenetic epidemiology. , 2012, International journal of epidemiology.

[14]  N. Pearce,et al.  Sample selection and validity of exposure–disease association estimates in cohort studies , 2010, Journal of Epidemiology & Community Health.

[15]  D. Lawlor,et al.  Clustered Environments and Randomized Genes: A Fundamental Distinction between Conventional and Genetic Epidemiology , 2007, PLoS medicine.

[16]  Shah Ebrahim,et al.  Observational versus randomised trial evidence , 2004, The Lancet.

[17]  A. Coats.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[18]  J Mark Elwood,et al.  Commentary: On representativeness. , 2013, International journal of epidemiology.

[19]  D. Lawlor,et al.  Vitamin C is not associated with coronary heart disease risk once life course socioeconomic position is taken into account: prospective findings from the British women’s heart and health study , 2005, Heart.

[20]  A. Kiss,et al.  Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. , 2007, JAMA.

[21]  Richard Horton,et al.  GBD 2010: understanding disease, injury, and risk , 2012, The Lancet.

[22]  G. Taubes.  Epidemiology faces its limits. , 1995, Science.

[23]  R. Stallones.  To advance epidemiology. , 1980, Annual review of public health.

[24]  G. Davey Smith,et al.  Epidemiology--is it time to call it a day? , 2001, International journal of epidemiology.

[25]  Sang Min Park,et al.  Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials , 2013, BMJ.

[26]  N. Pearce,et al.  Selection bias and patterns of confounding in cohort studies: the case of the NINFEA web-based birth cohort , 2011, Journal of Epidemiology & Community Health.

[27]  P. Sandercock,et al.  Where is the evidence that animal research benefits humans? , 2004, BMJ : British Medical Journal.

[28]  R. Collins.  What makes UK Biobank special? , 2012, The Lancet.

[29]  Jason C Morris.  The fall of the schizophrenogenic mother , 2012, The Lancet.